197 related articles for article (PubMed ID: 17451951)
1. Heterocyclic substituted cantharidin and norcantharidin analogues--synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity.
Hill TA; Stewart SG; Sauer B; Gilbert J; Ackland SP; Sakoff JA; McCluskey A
Bioorg Med Chem Lett; 2007 Jun; 17(12):3392-7. PubMed ID: 17451951
[TBL] [Abstract][Full Text] [Related]
2. Norcantharidin analogues: synthesis, anticancer activity and protein phosphatase 1 and 2A inhibition.
Hill TA; Stewart SG; Gordon CP; Ackland SP; Gilbert J; Sauer B; Sakoff JA; McCluskey A
ChemMedChem; 2008 Dec; 3(12):1878-92. PubMed ID: 19025735
[TBL] [Abstract][Full Text] [Related]
3. Cantharimides: a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A.
McCluskey A; Walkom C; Bowyer MC; Ackland SP; Gardiner E; Sakoff JA
Bioorg Med Chem Lett; 2001 Nov; 11(22):2941-6. PubMed ID: 11677131
[TBL] [Abstract][Full Text] [Related]
4. Anticancer activity and protein phosphatase 1 and 2A inhibition of a new generation of cantharidin analogues.
Sakoff JA; Ackland SP; Baldwin ML; Keane MA; McCluskey A
Invest New Drugs; 2002 Feb; 20(1):1-11. PubMed ID: 12003183
[TBL] [Abstract][Full Text] [Related]
5. Modified norcantharidins; synthesis, protein phosphatases 1 and 2A inhibition, and anticancer activity.
Hart ME; Chamberlin AR; Walkom C; Sakoff JA; McCluskey A
Bioorg Med Chem Lett; 2004 Apr; 14(8):1969-73. PubMed ID: 15050639
[TBL] [Abstract][Full Text] [Related]
6. Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumour cell lines.
McCluskey A; Ackland SP; Bowyer MC; Baldwin ML; Garner J; Walkom CC; Sakoff JA
Bioorg Chem; 2003 Feb; 31(1):68-79. PubMed ID: 12697169
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of norcantharidin analogues: towards PP1 selectivity.
Stewart SG; Hill TA; Gilbert J; Ackland SP; Sakoff JA; McCluskey A
Bioorg Med Chem; 2007 Dec; 15(23):7301-10. PubMed ID: 17870547
[TBL] [Abstract][Full Text] [Related]
8. The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design?
McCluskey A; Ackland SP; Gardiner E; Walkom CC; Sakoff JA
Anticancer Drug Des; 2001 Dec; 16(6):291-303. PubMed ID: 12375882
[TBL] [Abstract][Full Text] [Related]
9. Anhydride modified cantharidin analogues: synthesis, inhibition of protein phosphatases 1 and 2A and anticancer activity.
McCluskey A; Bowyer MC; Collins E; Sim ATR ; Sakoff JA; Baldwin ML
Bioorg Med Chem Lett; 2000 Aug; 10(15):1687-90. PubMed ID: 10937725
[TBL] [Abstract][Full Text] [Related]
10. Norcantharimides, synthesis and anticancer activity: Synthesis of new norcantharidin analogues and their anticancer evaluation.
Hill TA; Stewart SG; Ackland SP; Gilbert J; Sauer B; Sakoff JA; McCluskey A
Bioorg Med Chem; 2007 Sep; 15(18):6126-34. PubMed ID: 17606377
[TBL] [Abstract][Full Text] [Related]
11. The first two cantharidin analogues displaying PP1 selectivity.
McCluskey A; Keane MA; Walkom CC; Bowyer MC; Sim AT; Young DJ; Sakoff JA
Bioorg Med Chem Lett; 2002 Feb; 12(3):391-3. PubMed ID: 11814804
[TBL] [Abstract][Full Text] [Related]
12. Structural basis of serine/threonine phosphatase inhibition by the archetypal small molecules cantharidin and norcantharidin.
Bertini I; Calderone V; Fragai M; Luchinat C; Talluri E
J Med Chem; 2009 Aug; 52(15):4838-43. PubMed ID: 19601647
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Cytotoxicity of Octahydroepoxyisoindole-7-carboxylic Acids and Norcantharidin-Amide Hybrids as Norcantharidin Analogues.
Hizartzidis L; Gilbert J; Gordon CP; Sakoff JA; McCluskey A
ChemMedChem; 2019 Jun; 14(12):1152-1161. PubMed ID: 30938091
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anticancer activity of a series of norcantharidin analogues.
Tarleton M; Gilbert J; Sakoff JA; McCluskey A
Eur J Med Chem; 2012 Aug; 54():573-81. PubMed ID: 22796041
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activity of Delta-5,6-norcantharimides: importance of the 5,6-bridge.
Thaqi A; Scott JL; Gilbert J; Sakoff JA; McCluskey A
Eur J Med Chem; 2010 May; 45(5):1717-23. PubMed ID: 20153915
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of cantharidin analogues targeting protein phosphatase 2A.
Shan HB; Cai YC; Liu Y; Zeng WN; Chen HX; Fan BT; Liu XH; Xu ZL; Wang B; Xian LJ
Anticancer Drugs; 2006 Sep; 17(8):905-11. PubMed ID: 16940800
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of cantharidin analogues without bridging ether oxygen on human hepatocellular carcinoma cells.
Yeh CB; Su CJ; Hwang JM; Chou MC
Eur J Med Chem; 2010 Sep; 45(9):3981-5. PubMed ID: 20691337
[TBL] [Abstract][Full Text] [Related]
18. Norcantharimide analogues possessing terminal phosphate esters and their anti-cancer activity.
Robertson MJ; Gordon CP; Gilbert J; McCluskey A; Sakoff JA
Bioorg Med Chem; 2011 Sep; 19(18):5734-41. PubMed ID: 21855357
[TBL] [Abstract][Full Text] [Related]
19. The effects of cantharidin analogues on xanthine oxidase.
Tsauer W; Lin JG; Lin PY; Hsu FL; Chiang HC
Anticancer Res; 1997; 17(3C):2095-8. PubMed ID: 9216670
[TBL] [Abstract][Full Text] [Related]
20. Norcantharidin analogues: a patent review (2006 - 2010).
Deng L; Tang S
Expert Opin Ther Pat; 2011 Nov; 21(11):1743-53. PubMed ID: 22017412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
